原发性肝癌血管性介入治疗的现状

doi:10.3969/j.issn.1672-5069.2015.02.001

Abstract

Chen Dongfeng, Sun Wenjing. Current status on vascular interventional treatment of primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 225-227.

[1] 鲁东,吕维富. 肝癌血供研究进展. 中国介入影像与治疗学, 2007,4（3）:227-231.
[2] Kim SH,Kamaya A,Willmann JK. CT perfusion of the liver: principles and applications in oncology. Radiology,2014,272（2）:322-344.
[3] Cheng LF,Ma KF,Fan WC,et al. Hepatocellular carcinoma with extrahepatic collateral arterial supply. J Med Imaging Radiat Oncol,2010,54（1）:26-34.
[4] Rahbari NN,Mehrabi A,Mollberg NM,et al. Hepatocellular carcinoma:current management and perspectives for the future. Ann Surg,2011,253（3）:453-469.
[5] Lo C,Ngan H,Tso W. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology,2002,35（5）:1164-1171.
[6] Llovet J,Real M,Montana X. Arterial embolisation or chemoembolisation vs. symptomatic treatment in patients with unresectable hepatocellular carcinoma:a randomised controlled trial. Lancet,2002,359（9319）:1734-1739.
[7] Takayasu K,Arii S,Ikai I. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology,2006,131（2）:461-469.
[8] Zhao Y,Cai G,Zhou L,et al. Transarterial chemoembolization in hepatocellular carcinoma with vascular in invasion or extrahepatic metastasis:A systematic review. Asia Pac J Clin Oncol, 2013,9（4）:357-364.
[9] Talenfeld AD,Sista AK,Madoff DC. Transarterial therapies for primary liver tumors. Surg Oncol Clin N Am,2014,23（2）: 323-351.
[10] Bordoni A,Cerny A,Bihl F,et al. Survival of hepatocellular carcinoma patients is significantly improving:a population-based study from southern Switzerland. Cancer Epidemiol,2014,38（6）:679-685.
[11] Cabibbo G,Maida M,Genco C,et al. Natural history of untreatable hepatocellular carcinoma:A retrospective cohort study. World J Hepatol,2012,4（9）:256-261.
[12] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志,2011,14（2）：81-89.
[13] Lao XM, Luo G,Ye LT,et al. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma. Liver Int, 2013,33（4）:595-604.
[14] 葛茜,吴宇旋. 营养干预对原发性肝癌介入治疗患者效果评价. 实用预防医学,2009,16（3）:828-830.
[15] Dhanasekaran R,Limaye A,Cabrera R. Hepatocellular carcinoma:current trends in worldwide epidemiology,risk factors,diagnosis,and therapeutics. Hepat Med,2012,4:19-37.
[16] 张成武,赵大建,胡智明,等. 原发性肝癌经肝动脉栓塞化疗术后预后指标的多因素分析. 肝胆胰外科杂志,2007,19（6）: 376-379.
[17] Eswaran SL,Pierce K,Weaver F,et al. Transarterial chemoembolization for HCC in patients with extensive liver transplantation waiting times. Angiology,2012,63（3）:206-212.
[18] Yoo DJ,Kim KM,Jin YJ,et al. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma:does transarterial chemoembolization improve survival in these patients J Gastroenterol Hepatol, 2011,26（1）:145-154.
[19] Chung GE,Lee JH,Kim HY,et al. Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival. Radiology,2011,258（2）:627-634.
[20] Jeon SH,Park KS,Kim YH,et al. Incidence and risk factors of acute hepatic failure after transcatheter arterial embolization for hepatocellular carcinoma. Korean J Gastroenterol,2007,50（3）: 176-182.

Current status on vascular interventional treatment of primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[2]	Jin Juan, Zhou Shoulin, Gao Jing, et al.. Application of dignity therapy combined with psychological intervention in patients with end-stage primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 805-806.
[3]	Song Linquan, Liang Zhihong. Application of high frequency electric knife in hepatectomy in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 637-638.
[4]	Liu Shuhong, Liang Chenge, Xiang Yi, et al. Cost-efficacy of different nucleos(t)ides in the treatment of patients with hepatitis B-related primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 293-294.
[5]	Wang Lin, Liu Guohua. Application of polyvinyl alcohol microparticles in embolization of hepatic arteriovenousshunt during TACE in patients with hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 297-298.
[6]	Yi Jinlian, Zuo Lili, Ma Ruijie. Comprehensive nursing intervention in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 299-300.
[7]	Li Xue, Lyu Rongde. Self-efficacy intervention in patients with primary liver cancer after TACE and CIK treatment [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 307-308.
[8]	Wu Jinfeng,Bai Guodong,Cheng Rong. Combination of TACE and ultrasound-guided radiofrequency ablation in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 766-768.
[9]	He Aijun，Ren Yu.. Splenic management in patients with primary liver cancer underwent hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 571-574.
[10]	Cao Yan, Jiang Feng, Zhang Chao, et al.. Clinical effect of transcatheter hepatic arterial chemoembolization combined with CT-guided precision microwave ablation on patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 468-471.
[11]	Liu Tianbao, Liu Zhanhe, Wu Yuye. Trans-hepatic artery chemoembolization in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 507-508.
[12]	Liu Qunyi, Yu Guozheng, Yang Guangning, et al.. Clinical efficacy and safety of cool-tip microwave ablation combining transcatheter arterial chemoembolization in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 316-319.
[13]	Wu Zhenguo, Chen Yongyong, Li Nan. Clinical efficacy of radiofrequency ablation combined with TACE in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 324-327.
[14]	Xu Anbo, Hou Jiliu, Xu Qian. MRI scan and enhanced features of primary liver cancer and focal nodular hyperplasia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 333-336.
[15]	Dong Jing，Chen Zhaolin，Chen Xi，et al.. Efficacy of TACE combined with CIK cells for the treatment of patients with advanced primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 191-194.